Agilent Technologies Inc and Roche have announced the signing of an exclusive agreement to provide continued service to NimbleGen microarray customers as Roche phases out its NimbleGen array production and services. Researchers using ...
HTG Molecular Diagnostics has obtained ISO 13485:2003 certification for the design, manufacture, and distribution of its patented qNPA technology-based products and services used in the analysis of gene expression. qNPA molecular ...
Tags: ISO Certification, analysis of gene expression, medical technology
Allegro Diagnostics is set to present results of its BronchoGen genomic test, from Airway Epithelium Gene Expression In the Diagnosis of Lung Cancer (AEGIS) clinical trials, in a late-breaking abstract session at CHEST to be held on 23 ...
Affymetrix has launched SensationPlus FFPE Amplification and 3' IVT Labeling Kit (SensationPlus FFPE Reagent Kit). SensationPlus FFPE Reagent Kit, which comprises RNA amplification and labeling modules, is designed to enable gene ...
Tags: FFPE Reagent Kit, 3'IVT Labeling Kit, clinical technology
Life Technologies has introduced a new real-time PCR based molecular diagnostic instrument for diagnostic use in the Europe. The Applied Biosystems QuantStudio Dx instrument, which is released with Quidel Molecular assay for C. difficile, ...
Tags: molecular diagnostic instrument, diagnostic instrument, real-time PCR
Allegro Diagnostics has completed patient enrollment in 1,320-patient Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer II (AEGIS II) trial for BronchoGen genomic test. BronchoGen, which is built on the company's ...
Tags: clinical trial, clinical research, lung cancer molecular diagnostic
NanoString Technologies has reported positive results from a second validation study of its breast cancer assay based on the PAM50 gene expression signature. The CE-marked breast cancer assay is designed to provide a subtype ...
Tags: NanoString Technologies, breast cancer assay, PAM50 gene signature, study
HTG Molecular Diagnostics has partnered John Wayne Cancer Institute (JWCI) to sell its HTG melanoma signature assays. The signature assays are intended to be useful for diagnostic and prognostic applications along the melanoma continuum. ...
Tags: HTG Molecular, JWCI, melanoma signature, signature assays
DiaGenic has teamed up with GE Healthcare to develop a blood-based test using DiaGenic's peripheral gene expression profiling in patients with mild cognitive impairment, a disorder associated with risk for Alzheimer's Disease. The ...
Tags: DiaGenic, GE Healthcare, Alzheimer's Disease
Agendia, a developer of genomic-based diagnostic products, has unveiled ColoPrint microarray-based 18-gene expression signature. The ColoPrint assay provides critical additional information for treatment decisions for stage II colon ...
Tags: ColoPrint, Agendia, colon cancer patients
ZyGEM has signed an agreement to integrate its enzymatic RNA extraction technology into Quanta Biosciences' kits for quantitative PCR. The companies have kept further terms of the agreement confidential. ZyGEM CEO Paul Kinnon ...
Tags: enzymatic RNA extraction technology, clinical technology
HTG Molecular Diagnostics has collaborated with John Wayne Cancer Institute (JWCI) to market its HTG melanoma signature assays. The signature assays may be useful for diagnostic and prognostic applications along the melanoma ...
Tags: HTG melanoma signature assays, clinical technology, clinical research
HTG Molecular Diagnostics has gained rights to commercialize the Centre of Excellence for the Prevention of Organ Failure's(PROOF Centre)-developed gene expression blood tests,following the finalization of the license agreement. The gene ...
Tags: HTG Molecular Diagnostics, Prevention of Organ Failure, COPD, qNPA
Affymetrix and Centre for Proteomic and Genomic Research (CPGR) have entered into a service collaboration to advance genomic research services and personalized therapies in South Africa. Under the collaboration, CPGR will use Affymetrix ...
Tags: genomic research, gene expression
Allegro Diagnostics has presented positive results from a clinical trial of its BronchoGen genomic test, designed for the early detection of lung cancer in current and former smokers. Using the company's PCR molecular testing platform ...
Tags: clinical trial, genomic test, Lung Cancer Detection Assay